FCPM III SERVICES B.V. Long-Term Concentrated

Location: Naarden, Netherlands

CIK: 0002013410 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $722M (100.0% shares, 0.0% debt)

Holdings (10)

New Positions (1)

GLTO DAMORA THERAPEUTICS INC 8.8%

Value $63.22M Shares 2,441,000 Est. Cost $25.80 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
GLTO	DAMORA THERAPEUTICS INC	2,441,000	$63.22M	8.8%	$25.80	0.0%	COM NEW	36322Q206

Increased Positions (1)

VOR VOR BIOPHARMA INC 10.2%

Value $73.45M (+55.2%) Shares 4,117,354 (+13.8%) Est. Cost $20.05 Unrealized -30.2%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VOR	VOR BIOPHARMA INC	4,117,354 (+13.8%)	$73.45M (+55.2%)	10.2%	$20.05	-30.2%	COM NEW	929033207

Exited Positions (1)

RAPT RAPT THERAPEUTICS INC 8.6%

Value $62.09M Shares 1,833,333 Est. Cost $26.66 Unrealized +89.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RAPT	RAPT THERAPEUTICS INC	1,833,333	$62.09M	8.6%	$26.66	+89.5%	—	75382E208

Decreased Positions (1)

DYN DYNE THERAPEUTICS INC 11.7%

Value $84.2M (-21.2%) Shares 4,644,386 (-15.0%) Est. Cost $12.58 Unrealized +36.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
DYN	DYNE THERAPEUTICS INC	4,644,386 (-15.0%)	$84.2M (-21.2%)	11.7%	$12.58	+36.1%	COM	26818M108

Unchanged Positions (7)

NAMS NEWAMSTERDAM PHARMA COMPANY 40.8%

Value $294M Shares 9,198,900 Est. Cost $9.56 Unrealized +252.8%

ENGN ENGENE HOLDINGS INC 9.1%

Value $65.6M Shares 9,632,561 Est. Cost $10.14 Unrealized -4.7%

CBIO CRESCENT BIOPHARMA INC. 4.3%

Value $30.82M Shares 1,677,852 Est. Cost $12.74 Unrealized -13.2%

MPLT MAPLIGHT THERAPEUTICS INC 9.1%

Value $65.59M Shares 3,226,400 Est. Cost $16.75 Unrealized +5.2%

BCYC BICYCLE THERAPEUTICS PLC 2.2%

Value $16.09M Shares 3,468,430 Est. Cost $18.38 Unrealized —

REPL REPLIMUNE GROUP INC 3.0%

Value $21.48M Shares 2,808,368 Est. Cost $11.28 Unrealized -30.8%

ENGNW ENGENE HOLDINGS INC 1.0%

Value $7.282M Shares 2,878,148 Est. Cost $0.63 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	9,198,900	$294M	40.8%	$9.56	+252.8%	ORDINARY SHARES	N62509109
ENGN	ENGENE HOLDINGS INC	9,632,561	$65.6M	9.1%	$10.14	-4.7%	COM	29286M105
CBIO	CRESCENT BIOPHARMA INC.	1,677,852	$30.82M	4.3%	$12.74	-13.2%	COM	G2545C104
MPLT	MAPLIGHT THERAPEUTICS INC	3,226,400	$65.59M	9.1%	$16.75	+5.2%	COM	56565P103
BCYC	BICYCLE THERAPEUTICS PLC	3,468,430	$16.09M	2.2%	$18.38	—	SPONSORED ADS	088786108
REPL	REPLIMUNE GROUP INC	2,808,368	$21.48M	3.0%	$11.28	-30.8%	COM	76029N106
ENGNW	ENGENE HOLDINGS INC	2,878,148	$7.282M	1.0%	$0.63	—	W EXP 10/31/2028	29286M113